Loading
A live screen of the small-cap universe ordered by coverage-gap score — a composite of analyst count, last-coverage-change recency, and fundamental signal strength. Filter by cap, exchange, sector, and tier. Every row links to a source-backed profile.
State is in the URL. Share a filtered screen by copying the link.
| Ticker | Name · sector | Cap | ADV | Analysts | Tier | Gap , sorted ascending | Why surfaced |
|---|---|---|---|---|---|---|---|
| LTWJTNYSE | Falcrest Compute Software | $393M | $1.6M/d | 3 | covered | 39 | Tenant credit migration in the latest 10-K not yet flagged by the small-cohort sell-side. |
| GRMCNYSE | Granite Mountain Copper Materials | $412M | $1.8M/d | 2 | low coverage | 60 | Permitted expansion finalized post last analyst update; LOM extension materially understated. |
| NMARNYSE | Vante Materials Materials | $79M | $0.1M/d | 1 | low coverage | 63 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| QSCLCAMEX | Synd Cement Materials | $179M | $0.5M/d | 1 | low coverage | 63 | Channel structure obscures sell-through; alt-data flags acceleration. |
| ATLSNYSE | Atlas Cement Holdings Materials | $612M | $2.1M/d | 2 | low coverage | 64 | Two-coverage cohort, regional infrastructure spend re-rates input prices not yet reflected. |
| KSFQAMEX | Orval Mining Materials | $76M | $0.2M/d | 1 | low coverage | 68 | Channel structure obscures sell-through; alt-data flags acceleration. |
| WPGHNYSE | Hexor Sciences Healthcare | $49M | $0.2M/d | 1 | low coverage | 74 | No-coverage screen flag; recent insider buying not yet modeled. |
| GNRBAMEX | Ember Health Healthcare | $30M | $0.0M/d | 2 | low coverage | 75 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| ZEBRNYSE | Zebra Steel Wire Materials | $96M | $0.3M/d | 0 | no coverage | 79 | Sub-$100M cap, OEM concentration overstated by sell-side that no longer covers. |
| NTUNAMEX | Ember Compute Software | $214M | $0.9M/d | 0 | no coverage | 80 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| EBRWNYSE | Xander Steel Materials | $288M | $1.7M/d | 0 | no coverage | 81 | Channel structure obscures sell-through; alt-data flags acceleration. |
| VSPKAMEX | Falcrest Chemicals Materials | $195M | $0.4M/d | 0 | no coverage | 86 | Combined-ratio improvement on a tiny float; OTC listing keeps it off institutional desks. |
| ENGEAMEX | Ravell Health Healthcare | $124M | $0.5M/d | 0 | no coverage | 86 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |